医学
蛋白尿
肾病
免疫学
肾小球肾炎
泌尿科
内科学
肾
内分泌学
糖尿病
作者
Howard Trachtman,Radko Komers,Jula K. Inrig
标识
DOI:10.1080/1744666x.2024.2319132
摘要
Introduction IgA nephropathy is one of the most common forms of glomerular disease. Patients with persistent proteinuria are at increased risk of progression to kidney failure. There is a significant need for safe and effective therapies to lower proteinuria in these patients. Sparsentan is a non-immunosuppressive agent that acts as a dual angiotensin and endothelin receptor antagonist. It lowers proteinuria in experimental models of glomerular disease and in affected patients.
科研通智能强力驱动
Strongly Powered by AbleSci AI